NCT07505771 2026-04-06
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
Immunome, Inc.
Phase EARLY_PHASE1 Recruiting
Clinical Trials
10 trialsNCT02537418 2026-03-27
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
Canadian Cancer Trials Group
Phase 1 Active not recruiting
NCT05006794 2026-01-07
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Gilead Sciences
Phase 1 Active not recruiting
NCT06725381 2026-01-07
A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 1 Recruiting
NCT06600789 2025-11-03
A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies
Carrick Therapeutics Limited
Phase 1/2 Recruiting
NCT06933069 2025-09-11
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1 Recruiting
NCT00162136 2020-11-02
Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.
R-Pharm
Phase 1 Completed
NCT01540526 2019-11-19
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
University of Wisconsin, Madison
Phase 1 Completed
NCT02640755 2019-04-22
14C
AstraZeneca
Phase 1 Completed
NCT00033202 2009-06-03
This is an Early Study to Investigate the Effect of GimatecanĀ® in Adults With Solid Tumor
Sigma-Tau Research, Inc.
Phase 1 Completed